Literature DB >> 11028656

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma.

A Szczeklik1, E Nizankowska, M Duplaga.   

Abstract

There is a subset of patients with bronchial asthma who are susceptible to disease exacerbation upon receiving aspirin and other nonsteroidal anti-inflammatory drugs. This is a clinical syndrome, called aspirin-induced asthma (AIA), associated with alterations in arachidonate metabolism and cysteinyl-leukotriene overproduction. The natural history and clinical characteristics of this type of asthma were studied. Sixteen clinical centres in 10 European countries provided standardized information to the specially developed patient-oriented database regarding: medical history, physical examination, diagnosis, and treatment. Diagnosis of AIA was based on a typical history, confirmed by positive aspirin provocation tests, carried out in 91% of the patients. A total of 500 patients were enrolled in the study. AIA developed according to a pattern, characterized by a sequence of symptoms. First, persistent rhinitis, appearing at a mean age of 29.7+/-12.5 yrs, then asthma, aspirin intolerance and nasal polyposis appear. The clinical presentation in different European countries was remarkably similar. In females, who outnumbered males by 2.3:1, the onset of symptoms occurred significantly earlier and the disease was more progressive and severe than in males. Atopy, present in approximately a third of patients, led to earlier manifestation of rhinitis and asthma, but not of aspirin intolerance or nasal polyposis. A family history of aspirin intolerance, recorded in 6% of patients, had a less evident effect on the course of the disease than sex or atopy. Fifty one per cent of patients, in addition to inhaled steroids, required chronic systemic corticosteroid therapy at a mean dose of 8 mg prednisone x day(-1). Surprisingly, 15% of patients were unaware of intolerance to aspirin and learnt about it only after having provocation tests performed. All over Europe, aspirin-induced asthma develops in a similar characteristic way. Its course is influenced by sex and the presence of atopy. In half of the patients, asthma is severe, and steroid-dependent. The uniform natural history of aspirin-induced asthma might suggest a common underlying principle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028656     DOI: 10.1034/j.1399-3003.2000.016003432.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  123 in total

Review 1.  Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.

Authors:  Mark Rusznak; R Stokes Peebles
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-02

2.  KIF3A, a cilia structural gene on chromosome 5q31, and its polymorphisms show an association with aspirin hypersensitivity in asthma.

Authors:  Jeong-Hyun Kim; Ji-Yeon Cha; Hyun Sub Cheong; Jong Sook Park; An Soo Jang; Soo-Taek Uh; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byung-Lae Park; Joon Seol Bae; Choon-Sik Park; Hyoung Doo Shin
Journal:  J Clin Immunol       Date:  2010-10-05       Impact factor: 8.317

3.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

Review 4.  Role of medical therapy in the management of nasal polyps.

Authors:  Isam Alobid; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 5.  [Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease].

Authors:  C Umbreit; J C Virchow; C Thorn; K Hörmann; L Klimek; O Pfaar
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

6.  Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?

Authors:  Ludger Klimek; Ralph Dollner; Oliver Pfaar; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

7.  ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population.

Authors:  Takuro Sakagami; Nobuyoshi Jinnai; Toshiaki Nakajima; Takashi Sekigawa; Takashi Hasegawa; Eiichi Suzuki; Ituro Inoue; Fumitake Gejyo
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

8.  [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].

Authors:  U Förster-Ruhrmann; W Behrbohm; G Pierchalla; A J Szczepek; J W Fluhr; H Olze
Journal:  HNO       Date:  2019-08       Impact factor: 1.284

9.  Low prevalence of hypersensitivity to nonsteroidal anti-inflammatory drugs in Chinese patients with chronic rhinosinusitis.

Authors:  Yingshen Lu; Shuai Li; Lijuan Song; Hui Jin; Yanmei Li; Nanshan Zhong; Xiaowen Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-13       Impact factor: 2.503

10.  Nonsteroidal anti-inflammatory drug administration in children with history of wheeze.

Authors:  Kendra Sih; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.